BioData World Congress

Interview with the President of the European Institute for Innovation through Health Data

The interview was conducted by the DNAdigest team (dnadigest.org) Dipak Kalra is the President of the European Institute for Innovation through Health Data (i~HD). He is also a Professor of Health Informatics at University College London, and  affiliated with University of Gent. He has worked on the clinical, ethical and legal requirements for electronic health records and on the development of international interoperability standards and will present …

The BioData World Congress 2015 agenda preview is available to download

Held with the support of Intel, The Wellcome Trust Sanger Institute, The European Bioinformatics Institute, The Babraham Institute, BIA, BioNow, The Pharmacogenetics and Stratified Medicine Network and the Pistoia Alliance, BioData World Congress will: examine the science and technology that is shaping and revolutionising our understanding of disease and medicine review the game changing innovation, roadblocks and critical success factors …

Jimmy Lin of the Rare Genomics Institute: advancing gene therapies for rare disorders

Gene sequencing and replacement is no longer a distant and inaccessible practice for patients looking for faster diagnosis. However, when you're dealing with rare disorders, it is even harder to follow that path, as costs for sequencing are very high and replacing a gene in these cases, much more complex. Pharma is still betting more on a drug target strategy …

Speeding Up the Diagnosis of Rare Disease

The statistics…• There are between 6000 and 8000 rare diseases• 75% of rare diseases affect children• 30% of rare disease patients die before the age of 5• 80% of rare diseases have identified genetic origins Journal of IMAB – Annual Proceeding (Scientific Papers) 2011, vol. 17, book 1 Despite most rare diseases being genetically based, diagnostic testing for Orphan Diseases …

Treating fur mites can also alter mouse genetics

Here is a guest post from Faculty of 1000 (F1000) on a paper demonstrating that ivermectin treatment interferes with genetic experimentation in transgenic mice.   Transgenic animals, created by altering an organism’s genetic information through recombinant DNA technology, are invaluable in many facets of scientific research; they enable us to investigate genetic disorders, search for possible therapies and help us …